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ABSTRACT (250 words) 39	
 40	
Purpose: To report a case of solitary iris plasmacytoma successfully treated with 41	
ruthenium plaque radiotherapy 42	
 43	
Methods: A 44-year-old Caucasian female presented with right eye pain and raised 44	
intraocular pressure. Her past medical history included breast cancer treated 11 years 45	
earlier with lumpectomy, lymph node clearance, chemotherapy, and radiotherapy.  On 46	
examination, the right iris had a tan coloured mass with crystalline deposits visible on 47	
the mass surface and the corneal endothelium.  The fundus and left eye were 48	
normal.  Anterior segment ultrasound scan showed a mass with mixed internal 49	
echogenicity and internal blood flow. 50	
  51	
Results: An iris biopsy showed an infiltrate of plasma cells. Immunohistochemistry 52	
for kappa and lambda light chains demonstrated lambda light chain restriction. 53	
Systemic hematologic investigations, including complete blood count, serum 54	
paraproteins, bone marrow biopsy, and full body magnetic resonance image were 55	
normal. The monoclonal plasma cell infiltrate was consistent with a solitary iris 56	
plasmacytoma. The mass was treated with ruthenium plaque radiotherapy. After four 57	
years of follow up, the mass remained regressed and no systemic myeloma has 58	
developed.	59	
 60	
Conclusion: Iris plasmacytoma is rare and should prompt systemic evaluation to rule 61	
out multiple myeloma. Solitary iris plasmacytoma can be successfully treated with 62	
plaque radiotherapy.	63	
 64	
 65	
 66	
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 67	
INTRODUCTION	68	
 69	
Plasmacytoma is a neoplasm composed of monoclonal plasma cells and can occur as 70	
a solitary lesion or as a part of systemic multiple myeloma, a malignant plasma cell 71	
neoplasm. Solitary plasmacytomas are divided into solitary extramedullary or solitary 72	
bone plasmacytomas. Solitary extramedullary plasmacytomas most often develop in 73	
the head and neck, followed by gastrointestinal tract or lymph nodes.1 	74	
 75	
Ocular plasmacytoma is rare. It has been reported in the orbit and eyelid2, 76	
conjunctiva2, and uvea2–6. The majority of these cases, including those with iris 77	
plasmacytomas, were found in patients with systemic multiple myeloma. Shakin et al. 78	
reported a case with multiple myeloma and infiltration of the iris that simulated a 79	
nongranulomatous uveitis.5 Adkins et al.2 reported a 67-year-old patient with a history 80	
of multiple myeloma with raised intraocular pressure and iris thickening. You et al.6 81	
reported a case of an anterior uveal tract solitary plasmacytoma diagnosed and treated 82	
with iridociliary resection. Herein we describe a case of a solitary iris plasmocytoma 83	
diagnosed with an iris biopsy and treated with plaque radiotherapy.  84	
 85	
 86	
CASE REPORT	87	
 88	
A 44-year-old caucasian female presented with right frontal headache and painful 89	
right eye. Past medical history included breast cancer treated 11 years prior with 90	
lumpectomy, lymph node clearance, chemotherapy (including goserelin, tamoxifen, 91	
and adriamycin), radiotherapy, and oophorectomy as the cancer was oestrogen 92	
dependant.	93	
 94	
On examination, visual acuity was 6/4 in each eye. Her intraocular pressure (IOP) was 95	
raised in the right eye (51 mmHg) and normal in the left eye. In the right iris, a tan 96	
coloured lesion from 4 to 10 o’clock position was discovered (Figure 1A), with an 97	
episcleral sentinel blood vessel in the same quadrant. The lesion demonstrated 98	
overlying crystalline deposits which were also dispersed on the endothelial surface of 99	
the cornea (Figure 1B). Gonioscopy demonstrated a mass with surface crystals that 100	
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obscured the angle from 3 to 7 o’clock (Figure 1B). The left anterior segment was 101	
entirely normal. Dilated fundus examination of both eyes was normal. Transpupillary 102	
transillumination did not cast an abnormal shadow in the ciliary body of the right eye. 103	
Anterior segment ultrasound revealed a temporal and inferior elevated iris lesion that 104	
involved the inferior ciliary body. The lesion had mixed internal echogenicity and 105	
there was internal blood flow through the lesion with velocity in one vessel 15 cm/s. 106	
The lesion was 3.6 mm in elevation and had a base of 10.3 mm (transverse) by 4.2 107	
mm (longitudinal) (Figure 1C).	108	
 109	
Topical antihypertensive medications were commenced and a biopsy was taken. The 110	
iris biopsy showed an intense infiltrate of plasma cells and small numbers of 111	
lymphocytes (Figure 2). The plasma cells were massively expanded by 112	
immunoglobulin, with numerous Russell and Dutcher bodies. There was little nuclear 113	
atypia. Immunohistochemistry for kappa and lambda demonstrated lambda light chain 114	
restriction. The monoclonal plasma cell infiltrate was consistent with iris 115	
plasmacytoma. The patient underwent additional hematological investigations, 116	
including complete blood count, renal function and serum calcium levels which were 117	
all within the normal range.  There was no serum monoclonal paraprotein detected 118	
and the serum free light chain ratio was normal. A diffusion weighted magnetic 119	
resonance image of the whole body showed no lytic lesions or further plasmacytomas 120	
and there was no increase in clonal plasma cells on bone marrow biopsy. The urine 121	
was positive for Bence Jones protein.  This can occur in solitary extramedulary 122	
plasmacytoma without indicating multiple myeloma7.	123	
 124	
The diagnosis of solitary extramedullary plasmacytoma of the iris was made. A 125	
ruthenium-106 plaque applicator was used to deliver a radiation dose 40 Gy to the 126	
apex. This was placed overlying the cornea, centered on the inferior iris mass. 127	
Following treatment, the mass thickness regressed to ~1.0mm and the intraocular 128	
pressure normalized. After four years of follow-up, the patient remains free from local 129	
or systemic recurrence. There has been no residual cornea edema or decompensation. 130	
Interestingly, two years after the iris plasmacytoma was treated, she developed an 131	
unrelated oligodendroglioma (Grade III) for which she underwent local resection, 132	
chemotherapy, and radiotherapy. 	133	
 134	
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 135	
DISCUSSION 	136	
 137	
This case demonstrates a patient who presented with a solitary iris plasmacytoma 138	
diagnosed by iris biopsy and successfully treated with plaque radiotherapy. In 139	
addition, although this patient was not diagnosed with multiple myeloma, 140	
immunoglobulin crystals were found overlying the iris mass and the corneal 141	
endothelium. While similar crystal deposits are well recognized in multiple 142	
myeloma8, they have not been described in a solitary intraocular plasmacytoma.  143	
 144	
Radiotherapy has been the gold standard treatment for solitary plasmacytoma 145	
throughout the body.1 This is also true in ocular disease. Shields et al. described 146	
bilateral solitary extramedullary plasmacytoma of the ciliary body successfully treated 147	
with plaque radiotherapy4 as well as a solitary choroidal plasmacytoma successfully 148	
treated with external beam radiotherapy3. In this case, low-dose plaque radiotherapy 149	
led to a reduction in the iris mass and eventual total regression of the tumor. 	150	
 151	
The differential diagnosis of pale iris masses includes inflammatory granuloma, 152	
metastatic carcinoma, lymphoma, amelanotic melanoma, or as seen in this case a 153	
plasmacytoma. A biopsy should be undertaken in cases where plasmacytoma is a 154	
plausible diagnosis. If a diagnosis of iris plasmacytoma is made, prompt systemic 155	
evaluation should follow. While solitary bone plasmacytomas often progress to 156	
multiple myeloma (>75% of the time), solitary extramedullary plasmacytoma as 157	
diagnosed in this patient, has been reported to progress in less than 25% of patients.1		158	
Patients found to have multiple myeloma may require systemic treatment as well as 159	
local radiotherapy, emphasizing the need for thorough systemic workup. Long term 160	
follow-up, including systemic evaluation, is required as some patients with solitary 161	
ocular plasmacytoma can develop multiple myeloma. At 4 year’s follow-up, the 162	
present case remains in remission for the eye tumour and has not developed any other 163	
plasmacytoma or multiple myeloma.	164	
 165	
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FIGURES 193	 	194	 Figure	1	195	 	196	
A: A tan colored mass in the inferior aspect of the right iris. B: Gonioscopy reveals 197	
the lesion with crystals overlying the iris lesion as well as on the corneal endothelial 198	
surface. The associated angle is closed.	C:	An ultrasound shows the iris lesion 199	
involving the anterior ciliary body prior to radiotherapy with a thickness of 3.6mm.	200	
  201	 	202	 Figure	2	203	 A	low-magnification view of the iris biopsy shows plasma cell infiltration with small 204	
numbers of lymphocytes. 	205	
  206	 	207	
